From uncovering new benefits of semaglutide to targeting hypercortisolism in people with type 2 diabetes, here are 5 key updates from the annual meeting.
Subodh Verma, MD, PhD
Advertisement
Cardiac surgeon-scientist and Professor at University of Toronto and Tier 1 Canada Research Chair in Cardiovascular Surgery
Articles by Subodh Verma, MD, PhD
Verma discussed how recent advances in the field affect clinician management of type 2 diabetes and peripheral artery disease.
Verma discussed how new data from the STRIDE trial support the role of GLP-1 RAs as protective vascular medications.
Verma went over the STRIDE trial evaluating the GLP-1 RA and its latest findings presented at ADA Scientific Sessions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5